EBITDA: Income before interest, taxes, depreciation and amortization.
Tectonic Therapeutic, Inc. (TECX) had EBITDA of $-21.18M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-19.23M |
|
-- |
|
-- |
|
$21.52M |
|
$-21.52M |
|
$2.54M |
|
$-18.97M |
|
$-18.97M |
|
$-19.23M |
|
$-19.23M |
|
$-19.23M |
|
$-19.23M |
|
$-21.52M |
|
|
EBITDA |
$-21.18M |
18.32M |
|
18.32M |
|
$-1.03 |
|
$-1.03 |
|
| Balance Sheet Financials | |
$257.36M |
|
$1.19M |
|
$3.68M |
|
$261.04M |
|
$9.67M |
|
$0.04M |
|
$0.04M |
|
$9.71M |
|
$251.33M |
|
$251.33M |
|
$251.33M |
|
18.74M |
|
| Cash Flow Statement Financials | |
$-60.08M |
|
$-0.14M |
|
$173.35M |
|
$141.83M |
|
$254.87M |
|
$113.04M |
|
$10.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.63 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.65% |
|
-7.65% |
|
-7.37% |
|
-7.65% |
|
$13.41 |
|
$-3.29 |
|
$-3.28 |
|